UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Aprokam-50mg-Powder-SE-IS-MPD-BBDL

Aprokam 50 mg Pulver till injektionsvätska, lösning

MPID: SE-100001677-00046149
EURDID: 615

Full name: Aprokam 50 mg Pulver till injektionsvätska, lösning

- Invented name part: Aprokam

- Strength part: 50 mg

- Pharmaceutical dose form part: pulver till injektionsvätska, lösning

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Powder for solution for injection

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000093533 S01AA27

Marketing Authorisation 1 of 1

Authorisation number: 46149

Region: Kingdom of Sweden

Marketing authorisation holder: Laboratoires THEA

Identifier:

  • LOC-100005605

Status: Valid (2012-07-12)

Package 1 of 2

PCID:

Description:
Injektionsflaska, 10 x 50 mg

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 10 Vial

Package: 1 Box (Cardboard)

Containing:

Package: 10 Vial (Cardboard)

Containing:

Package: 1 Vial (Glass)

Containing: 1 Vial

Manufactured Item

Dose form: Powder for solution for injection

Unit of presentation: Vial

Ingredient

Role: Active

Substance: cefuroxime sodium

Concentration strength: 52.6 milligram(s) / 1 unit(s)

Reference strength:
cefuroxime 50 milligram(s) / 1 unit(s)

Package 2 of 2

PCID:

Description:
Injektionsflaska, 10 x 50 mg (inkl 10 sterila kanyler)

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 10 Vial

Package: 1 Box (Cardboard)

Containing:

Package: 10 Vial (Glass)

Containing: 10 vial

Manufactured Item

Dose form: Powder for solution for injection

Unit of presentation: Vial

Ingredient

Role: Active

Substance: cefuroxime sodium

Concentration strength: 52.6 milligram(s) / 1 unit(s)

Reference strength:
cefuroxime 50 milligram(s) / 1 unit(s)

Administrable Product (1 of 1)

Dose form: Solution for injection

Unit of presentation:

Route of administration:

  • Intracameral use

Ingredients:

Ingredient

Role: Active

Substance: cefuroxime sodium

Concentration strength: 52.6 milligram(s) / 1 unit(s)

Reference strength:
cefuroxime 50 milligram(s) / 1 unit(s)